251 related articles for article (PubMed ID: 23971452)
41. Clear cell renal cell carcinoma: multiphasic MDCT enhancement can predict the loss of chromosome 8p.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Young JA; Hsu M; Raman SS
Abdom Imaging; 2014 Jun; 39(3):543-9. PubMed ID: 24573763
[TBL] [Abstract][Full Text] [Related]
42. Small (<4 cm) clear cell renal cell carcinoma: correlation between CT findings and histologic grade.
Choi SY; Sung DJ; Yang KS; Kim KA; Yeom SK; Sim KC; Han NY; Park BJ; Kim MJ; Cho SB; Lee JH
Abdom Radiol (NY); 2016 Jun; 41(6):1160-9. PubMed ID: 27040407
[TBL] [Abstract][Full Text] [Related]
43. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
[TBL] [Abstract][Full Text] [Related]
44. Histotype differentiation of hypo-echoic renal tumors on CEUS: usefulness of enhancement homogeneity and intensity.
Lu Q; Xue LY; Huang BJ; Wang WP; Li CX
Abdom Imaging; 2015 Aug; 40(6):1675-83. PubMed ID: 25549784
[TBL] [Abstract][Full Text] [Related]
45. Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors.
Gorin MA; Rowe SP; Baras AS; Solnes LB; Ball MW; Pierorazio PM; Pavlovich CP; Epstein JI; Javadi MS; Allaf ME
Eur Urol; 2016 Mar; 69(3):413-6. PubMed ID: 26386607
[TBL] [Abstract][Full Text] [Related]
46. [How accurate is the correlation between clinical and pathological TNM stages in renal tumours?].
Frommhold J; Jocham D; Doehn C
Aktuelle Urol; 2011 Jul; 42(4):247-51. PubMed ID: 21717400
[TBL] [Abstract][Full Text] [Related]
47. Clinico-radio-pathologic features of a solitary solid renal mass at MDCT examination.
Kim EY; Park BK; Kim CK; Lee HM
Acta Radiol; 2010 Dec; 51(10):1143-8. PubMed ID: 20849320
[TBL] [Abstract][Full Text] [Related]
48. Clear cell renal cell carcinoma and papillary renal cell carcinoma: differentiation of distinct histological types with multiphase CT.
Bata P; Gyebnar J; Tarnoki DL; Tarnoki AD; Kekesi D; Szendroi A; Fejer B; Szasz AM; Nyirady P; Karlinger K; Berczi V
Diagn Interv Radiol; 2013; 19(5):387-92. PubMed ID: 23864331
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass Histology.
Kay FU; Canvasser NE; Xi Y; Pinho DF; Costa DN; Diaz de Leon A; Khatri G; Leyendecker JR; Yokoo T; Lay AH; Kavoussi N; Koseoglu E; Cadeddu JA; Pedrosa I
Radiology; 2018 May; 287(2):543-553. PubMed ID: 29390196
[TBL] [Abstract][Full Text] [Related]
50. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
[TBL] [Abstract][Full Text] [Related]
51. Sarcomatoid Renal Cell Carcinoma and Collecting Duct Carcinoma: Discrimination From Common Renal Cell Carcinoma Subtypes and Benign RCC Mimics on Multiphasic MDCT.
Young JR; Young JA; Margolis DJA; Sauk S; Sayre J; Pantuck AJ; Raman SS
Acad Radiol; 2017 Oct; 24(10):1226-1232. PubMed ID: 28528853
[TBL] [Abstract][Full Text] [Related]
52. Significance of peritumoral vascularity on CT in evaluation of renal cortical tumor.
Zhang J; Lefkowitz RA; Wang L; Ishill NM; Moskowitz CS; Russo P; Hricak H
J Comput Assist Tomogr; 2007; 31(5):717-23. PubMed ID: 17895782
[TBL] [Abstract][Full Text] [Related]
53. Does Computed Tomography Still Have Limitations to Distinguish Benign from Malignant Renal Tumors for Radiologists?
Shin T; Duddalwar VA; Ukimura O; Matsugasumi T; Chen F; Ahmadi N; de Castro Abreu AL; Mimata H; Gill IS
Urol Int; 2017; 99(2):229-236. PubMed ID: 28268233
[TBL] [Abstract][Full Text] [Related]
54. Preoperative staging of renal cell carcinoma with multidetector CT.
Türkvatan A; Akdur PO; Altinel M; Olçer T; Turhan N; Cumhur T; Akinci S; Ozkul F
Diagn Interv Radiol; 2009 Mar; 15(1):22-30. PubMed ID: 19263370
[TBL] [Abstract][Full Text] [Related]
55. Low enhancement on multiphase contrast-enhanced CT images: an independent predictor of the presence of high tumor grade of clear cell renal cell carcinoma.
Zhu YH; Wang X; Zhang J; Chen YH; Kong W; Huang YR
AJR Am J Roentgenol; 2014 Sep; 203(3):W295-300. PubMed ID: 25148187
[TBL] [Abstract][Full Text] [Related]
56. CCND1 rearrangements and cyclin D1 overexpression in renal oncocytomas: frequency, clinicopathologic features, and utility in differentiation from chromophobe renal cell carcinoma.
Sukov WR; Ketterling RP; Lager DJ; Carlson AW; Sinnwell JP; Chow GK; Jenkins RB; Cheville JC
Hum Pathol; 2009 Sep; 40(9):1296-303. PubMed ID: 19386349
[TBL] [Abstract][Full Text] [Related]
57. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
58. Differentiation of Renal Tumor Histotypes: Usefulness of Quantitative Analysis of Contrast-Enhanced Ultrasound.
Lu Q; Huang BJ; Xue LY; Fan PL; Wang WP
AJR Am J Roentgenol; 2015 Sep; 205(3):W335-42. PubMed ID: 26295670
[TBL] [Abstract][Full Text] [Related]
59. Renal oncocytoma growth rates before intervention.
Kurup AN; Thompson RH; Leibovich BC; Harmsen WS; Sebo TJ; Callstrom MR; Kawashima A; Atwell TD
BJU Int; 2012 Nov; 110(10):1444-8. PubMed ID: 22520366
[TBL] [Abstract][Full Text] [Related]
60. Sporadic renal hybrid oncocytic/chromophobe tumor in a young woman.
Kong L; Pan Z; Pei C; Kong Z
Asian J Surg; 2024 Jun; 47(6):2899-2900. PubMed ID: 38383182
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
